A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/11487742
Conclusion of this study
A 4-month period of DHA supplementation (345 mg/d) does not decrease symptoms of ADHD.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
Body systems related to this study
 Nervous System |
